Related Experiment Videos
Monitoring early inflammation in CF. Infant pulmonary function testing
1Children's Hospital of Buffalo, Lung Center, 219 Bryant St., Buffalo, NY 14222, USA.
Insights
Infant pulmonary function tests (iPFTs) are crucial research tools for understanding lung abnormalities in infants with cystic fibrosis (CF). This review details iPFT methods and findings, aiming to improve early diagnosis and management of CF lung disease.
Area of Science:
- Pediatric Pulmonology
- Respiratory Physiology
- Cystic Fibrosis Research
Background:
- Infant pulmonary function tests (iPFTs) are primarily research tools.
- They help define physiologic pulmonary abnormalities in young children with cystic fibrosis (CF).
Purpose of the Study:
- To describe methodologies for measuring infant pulmonary function.
- To present a comprehensive review of iPFT studies and findings in infants with CF.
- To outline future goals for refining iPFT methodologies and characterizing CF pulmonary disease.
Main Methods:
- Review of existing literature on infant pulmonary function testing.
- Focus on methodologies applicable to infants and young children.
- Specific consideration of studies involving cystic fibrosis patients.
Main Results:
- iPFTs are valuable for research in pediatric CF.
- Established methodologies exist for assessing infant lung function.
- Published studies provide insights into pulmonary abnormalities in CF infants.
Conclusions:
- iPFTs are essential for advancing the understanding of CF lung disease in infants.
- Methodological improvements are needed for broader clinical application.
- Further research will refine the definition and management of pulmonary disease in early CF.
Abstract:
Infant pulmonary function tests (iPFTs) have primarily been used as research tools to further define physiologic pulmonary abnormalities in infants and young children with cystic fibrosis (CF). Methodologies used to measure pulmonary function in infants are described, with particular relevance to CF. A comprehensive review of studies and findings in CF infants using iPFTs is presented. Further goals in improving methodologies and in defining pulmonary disease in CF are presented.